Lower cellular immune responses to influenza A (H3N2) in the elderly

Journal of Medical Virology

Volumn 81, Issue 8, 2009, Pages 1471-1476

  Jia, Na ^a   Li, Chris ^b   Liu, Yun Xi ^c   Richardus, Jan H ^d   Feng, Dan ^c   Yang, Hong ^a   Dang, Rong Li ^e   Ma, Yong Hong ^e   Xu, Xiao Ning ^b   Cao, Wu Chun ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e Center for Disease Control and Prevention in Xinjiang Military Command   (China)

Author keywords

Antibody; Cellular immunity; Elderly persons; Influenza

Indexed keywords

GAMMA INTERFERON; PROTEOME;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; CLINICAL EVALUATION; COHORT ANALYSIS; DEMOGRAPHY; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; OUTCOME ASSESSMENT; PATIENT SELECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VACCINATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHINA; COHORT STUDIES; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; INTERFERON-GAMMA; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

ORTHOMYXOVIRIDAE;

EID: 68049103160     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21544     Document Type: Article

References (39)

1. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, Johnston MN, Corcoran C, Wurcel AG, Fitzpatrick CA, Feeney ME, Rodriguez WR, Basgoz N, Draenert R, Stone DR, Brander C, Goulder PJ, Rosenberg ES, Altfeld M, Walker BD. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77:2081-2092. (Pubitemid 36110021)
2. Ahmed R, Gray D. 1996. Immunological memory and protective immunity: Understanding their relation. Science 272:54-60. (Pubitemid 26110754)
3. Almanzar G, Herndler-Brandstetter D, Chaparro SV, Jenewein B, Keller M, Grubeck-Loebenstein B. 2007. Immunodominant peptides from conserved influenza proteins - A tool for more efficient vaccination in the elderly? Wien Med Wochenschr 157:116-121.
4. Askonas BA, Mullbacher A, Ashman RB. 1982. Cytotoxic T-memory cells in virus infection and the specificity of helper T cells. Immunology 45:79-84. (Pubitemid 12251009)
5. Aw D, Silva AB, Palmer DB. 2007. Immunosenescence: Emerging challenges for an ageing population. Immunology 120:435-446. (Pubitemid 46365019)
6. Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko DM. 1999. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 17:82-94. (Pubitemid 28470736)
7. Brett SJ, Blau J, Hughes-Jenkins CM, Rhodes J, Liew FY, Tite JP. 1991. Human T cell recognition of influenza A nucleoprotein. Specificity and genetic restriction of immunodominant T helper cell epitopes. J Immunol 147:984-991.
8. Castle SC. 2000. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 31:578-585. (Pubitemid 32289594)
9. Danke NA, Kwok WW. 2003. HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J Immunol 171:3163-3169.
10. Deng Y, Jing Y, Campbell AE, Gravenstein S. 2004. Age-related impaired type 1 T cell responses to influenza: Reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 172:3437-3446. (Pubitemid 38337923)
11. Doherty PC. 2007. Effector CD4+ and CD8+ T cell mechanisms in the control of respiratory virus infections. Immunol Rev 159:105-117.
12. Effros RB. 2007. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 25:599-604.
13. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P. 2000. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 95:2860-2868. (Pubitemid 30235896)
14. Gravenstein S, Drinka P, Duthie EH, Miller BA, Brown CS, Hensley M, Circo R, Langer E, Ershler WB. 1994. Efficacy of an influenza hemagglutinin- diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J Am Geriatr Soc 42:245-251. (Pubitemid 24079864)
15. He XS, Holmes TH, Zhang C, Mahmood K, Kemble GW, Lewis DB, Dekker CL, Greenberg HB, Arvin AM. 2006. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80:11756-11766. (Pubitemid 44788888)
16. Heron MP, Smith BL. 2007. Deaths: Leading causes for 2003. Natl Vital Stat Rep 55:1-92.
17. Jameson J, Cruz J, Ennis FA. 1998. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol 72:8682-8689. (Pubitemid 28471808)
18. Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, Craft J. 2004. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 173:673-681. (Pubitemid 38797398)
19. Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. 2007. Age-related changes in immunity: Implications for vaccination in the elderly. Expert Rev Mol Med 9:1-17. (Pubitemid 46322025)
20. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. 1997. Rapid effector function in CD8+ memory T cells. J Exp Med 186:859-865. (Pubitemid 27407347)
21. Lazuardi L, Jenewein B, Wolf AM, Pfister G, Tzankov A, Grubeck- Loebenstein B. 2005. Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology 114:37-43. (Pubitemid 40030291)
22. Liu M, Liu GF, Wang Y, Zhao W, Wang L, Shi W, Wen SY. 2005. Study on the effectiveness and cost-benefit of influenza vaccine on elderly population in Beijing city. Zhonghua Liu Xing Bing Xue Za Zhi 26:412-416.
23. McElhaney JE. 2005. The unmet need in the elderly: Designing new influenza vaccines for older adults. Vaccine 23:S10-S25.
24. McElhaney JE, Dutz JP. 2008. Better influenza vaccines for older people: What will it take? J Infect Dis 198:632-634.
25. McElhaney JE, Gravenstein S, Upshaw CM, Hooton JW, Krause P, Drinka P. 1998. Immune response to influenza vaccination in institutionalized elderly: Effect on different T-cell subsets. Vaccine 16:403-409. (Pubitemid 28012253)
26. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, Ewen C, Kane KP, Bleackley RC. 2006. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176:6333-6339.
27. Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, Abrutyn E. 2002. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 37:427-439. (Pubitemid 34073561)
28. Rock KL, Shen L. 2005. Cross-presentation: Underlying mechanisms and role of immune surveillance. Immunol Rev 207:166-183. (Pubitemid 41415016)
29. Shu YL, Zhang Y, Wen LY, Li Z, Guo JF, Wang M, Yu HJ, Yang WZ, Guo YJ. 2005. Antigenic and genetic study of hemagglutinin gene of influenza virus (H3N2) circulated in China in 2004. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 19:362-365.
30. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. 1998. Pandemic versus epidemic influenza mortality: A pattern of changing age distribution. J Infect Dis 178:53-60. (Pubitemid 28328076)
31. Skowronski DM, Tweed SA, De Serres G. 2008. Rapid decline of influenza vaccine-induced antibody in the elderly: Is it real, or is it relevant? J Infect Dis 197:490-502. (Pubitemid 351321525)
32. Steinmann GG, Klaus B, Muller-Hermelink HK. 1985. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 22:563-575. (Pubitemid 16174333)
33. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. 2006. Cell-mediated protection in influenza infection. Emerg Infect Dis 12:48-54.
34. Wang QY, Dong ZY, Wu J, Gao T, Xu M, He X. 2004. Logistic regression analysis of vaccination of influenza vaccine in Beijing City community resident. Zhonghua Liu Xing Bing Xue Za Zhi 25:999.
35. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B. 2008. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 46:1078-1084. (Pubitemid 351589876)
36. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. 2008. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 205:711-723.
37. Yap FH, Ho PL, Lam KF, Chan PK, Cheng YH, Peiris JS. 2004. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 73:617-623.
38. Yewdell JW, Haeryfar SM. 2005. Understanding presentation of viral antigens to CD8 T cells in vivo: The key to rational vaccine design. Annu Rev Immunol 23:651-682.
39. Zhang Y, Li Z, Guo JF, Wang M, Wen LY, Guo YJ. 2003. Influenza activity in China from 2000 to 2001. Zhonghua Liu Xing Bing Xue Za Zhi 24:4-8